NCT04211571View on ClinicalTrials.gov

Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function

NACompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

April 23, 2020

Primary Completion Date

September 17, 2023

Study Completion Date

September 24, 2023

Conditions
End Stage Renal Disease
Interventions
DEVICE

Theranova 400 dialyzer

Hemodialysis using Theranova 400 dialyzer

DEVICE

High-flux dialyzer

Hemodialysis using high-flux dialyzer

Trial Locations (1)

Unknown

Kyungpook national university chilgok hospital, Daegu

All Listed Sponsors
collaborator

Kyungpook National University Chilgok Hospital

OTHER

collaborator

Yeungnam University Hospital

OTHER

collaborator

Ewha Womans University

OTHER

collaborator

Baxter Healthcare Corporation

INDUSTRY

lead

Kyungpook National University Hospital

OTHER

NCT04211571 - Theranova Versus High-flux Dialyzer on Preservation of Residual Renal Function | Biotech Hunter | Biotech Hunter